Phenylalanine determined in plasma with use of phenylalanine dehydrogenase and a centrifugal analyzer.


Por: Vilaseca MA, Farre C and Ramón F

Publicada: 1 ene 1993
Resumen:
Quantitative determination of plasma phenylalanine (Phe) is essential for the diagnosis of phenylketonuria (PKU) and the control of dietary therapy of PKU patients. We have adapted a spectrophotometric method (Clin Chim Acta 1991;201:95-8) based on phenylalanine dehydrogenase (EC 1.4.1.-) for rapid and accurate determinations of Phe with the Cobas Fara II centrifugal analyzer. The method is based on the NAD(H)-dependent reductive deamination of Phe with large amounts of phenylalanine dehydrogenase, which catalyzes the formation of phenylpyruvate at pH 10.8. Combining the specificity of the phenylalanine dehydrogenase with the precision, accuracy, and considerable time-saving of an automated system is useful for monitoring PKU patients in a children's hospital.
ISSN: 00099147





CLINICAL CHEMISTRY
Editorial
AMER ASSOC CLINICAL CHEMISTRY, 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526, Estados Unidos America
Tipo de documento: Article
Volumen: 39 Número: 1
Páginas: 129-131
WOS Id: A1993KG57100023
ID de PubMed: 8419035

MÉTRICAS